Uneven hepatic copper distribution in Wilson's disease. 1995

G Faa, and V Nurchi, and L Demelia, and R Ambu, and G Parodo, and T Congiu, and R Sciot, and P Van Eyken, and R Silvagni, and G Crisponi
Dipartimento di Citomorfologia-Sezione Anatomia Patologica, University of Cagliari, Italy.

OBJECTIVE Determination of hepatic copper concentration is important in the diagnosis of Wilson's disease. We studied copper distribution in the cirrhotic liver of a patient who died of Wilson's disease. METHODS A liver slice extending from the left to the right lobe was divided into 38 samples. Each sample was analyzed for copper content by Induced Coupled Plasma Atomic Emission Spectroscopy. RESULTS The mean copper concentration in the liver was 1370 micrograms/g dt. A striking variability, up to 2-3-fold, in copper levels was observed between the samples: the copper concentration ranged from 880 to 2100 micrograms/g dt, with significant differences even between adjacent samples. Lobar differences were also observed, with a tendency of the right lobe to accumulate more copper than the left lobe. Histochemical analyses confirmed the uneven distribution of copper even at the acinar level. Copper was mainly stored in periportal hepatocytes (zone 1) and at the periphery of the regenerating nodules. Moreover, we observed some nodules with the majority of hepatocytes full of copper granules, adjacent to areas of parenchyma negative for copper stains. CONCLUSIONS Our data show that: 1) copper is unevenly distributed in Wilson's disease in the cirrhotic stage; 2) a lobar pattern of copper distribution is evident in this case, characterized by a higher copper concentration in the right lobe; 3) the observed lobar pattern is different from that described in the newborn liver, characterized by a higher copper content in the left compartment of the liver; 4) copper content determined in a small liver sample cannot be considered as absolutely representative of the mean hepatic copper concentration. From a practical point of view, our data show that sampling variability deserves more consideration in the diagnosis and in the monitoring of Wilson's disease. The use of hepatic copper concentration in monitoring the efficacy of the copper-chelating therapy may be unreliable, particularly in the cirrhotic stage, because of the patchy distribution of copper, as demonstrated in this study.

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008297 Male Males
D003300 Copper A heavy metal trace element with the atomic symbol Cu, atomic number 29, and atomic weight 63.55. Copper-63,Copper 63
D006527 Hepatolenticular Degeneration A rare autosomal recessive disease characterized by the deposition of copper in the BRAIN; LIVER; CORNEA; and other organs. It is caused by defects in the ATP7B gene encoding copper-transporting ATPase 2 (EC 3.6.3.4), also known as the Wilson disease protein. The overload of copper inevitably leads to progressive liver and neurological dysfunction such as LIVER CIRRHOSIS; TREMOR; ATAXIA and intellectual deterioration. Hepatic dysfunction may precede neurologic dysfunction by several years. Cerebral Pseudosclerosis,Neurohepatic Degeneration,Pseudosclerosis,Wilson Disease,Copper Storage Disease,Hepatic Form of Wilson Disease,Hepato-Neurologic Wilson Disease,Hepatocerebral Degeneration,Hepatolenticular Degeneration Syndrome,Kinnier-Wilson Disease,Progressive Lenticular Degeneration,Westphal-Strumpell Syndrome,Wilson Disease, Hepatic Form,Wilson's Disease,Cerebral Pseudoscleroses,Copper Storage Diseases,Degeneration Syndrome, Hepatolenticular,Degeneration Syndromes, Hepatolenticular,Degeneration, Hepatocerebral,Degeneration, Hepatolenticular,Degeneration, Neurohepatic,Degeneration, Progressive Lenticular,Degenerations, Hepatocerebral,Degenerations, Neurohepatic,Disease, Copper Storage,Diseases, Copper Storage,Diseases, Hepato-Neurologic Wilson,Diseases, Kinnier-Wilson,Hepato Neurologic Wilson Disease,Hepato-Neurologic Wilson Diseases,Hepatocerebral Degenerations,Hepatolenticular Degeneration Syndromes,Kinnier Wilson Disease,Kinnier-Wilson Diseases,Lenticular Degeneration, Progressive,Neurohepatic Degenerations,Pseudoscleroses, Cerebral,Pseudosclerosis, Cerebral,Storage Disease, Copper,Storage Diseases, Copper,Syndrome, Hepatolenticular Degeneration,Syndromes, Hepatolenticular Degeneration,Westphal Strumpell Syndrome,Westphal-Strumpell Syndromes,Wilson Disease, Hepato-Neurologic,Wilson Diseases, Hepato-Neurologic,Wilsons Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies
D017809 Fatal Outcome Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept. Fatal Outcomes,Outcome, Fatal,Outcomes, Fatal

Related Publications

G Faa, and V Nurchi, and L Demelia, and R Ambu, and G Parodo, and T Congiu, and R Sciot, and P Van Eyken, and R Silvagni, and G Crisponi
December 2013, Scandinavian journal of gastroenterology,
G Faa, and V Nurchi, and L Demelia, and R Ambu, and G Parodo, and T Congiu, and R Sciot, and P Van Eyken, and R Silvagni, and G Crisponi
October 1987, Laboratory investigation; a journal of technical methods and pathology,
G Faa, and V Nurchi, and L Demelia, and R Ambu, and G Parodo, and T Congiu, and R Sciot, and P Van Eyken, and R Silvagni, and G Crisponi
October 1983, Archives of pathology & laboratory medicine,
G Faa, and V Nurchi, and L Demelia, and R Ambu, and G Parodo, and T Congiu, and R Sciot, and P Van Eyken, and R Silvagni, and G Crisponi
April 1994, Australian and New Zealand journal of medicine,
G Faa, and V Nurchi, and L Demelia, and R Ambu, and G Parodo, and T Congiu, and R Sciot, and P Van Eyken, and R Silvagni, and G Crisponi
February 1964, Archives of disease in childhood,
G Faa, and V Nurchi, and L Demelia, and R Ambu, and G Parodo, and T Congiu, and R Sciot, and P Van Eyken, and R Silvagni, and G Crisponi
February 2023, Diagnostics (Basel, Switzerland),
G Faa, and V Nurchi, and L Demelia, and R Ambu, and G Parodo, and T Congiu, and R Sciot, and P Van Eyken, and R Silvagni, and G Crisponi
September 2015, The Journal of clinical investigation,
G Faa, and V Nurchi, and L Demelia, and R Ambu, and G Parodo, and T Congiu, and R Sciot, and P Van Eyken, and R Silvagni, and G Crisponi
May 2017, Seminars in liver disease,
G Faa, and V Nurchi, and L Demelia, and R Ambu, and G Parodo, and T Congiu, and R Sciot, and P Van Eyken, and R Silvagni, and G Crisponi
December 1968, The American journal of pathology,
G Faa, and V Nurchi, and L Demelia, and R Ambu, and G Parodo, and T Congiu, and R Sciot, and P Van Eyken, and R Silvagni, and G Crisponi
January 1987, Hepatology (Baltimore, Md.),
Copied contents to your clipboard!